GSA Capital Partners »

Crinetics Pharmaceuticals In shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $323k 9.1k 35.56
2023-09-30 $328k 11k 29.75
2023-06-30 $634k 35k 18.02
2023-03-31 $473k 30k 16.06
2022-03-31 $327k 15k 21.95
2021-12-31 $350k 12k 28.37
2021-09-30 $347k 17k 21.06